The H3K27me3 demethylase UTX in normal development and disease

Area of Science:

• Epigenetics
• Molecular Biology
• Developmental Biology

Background:

• Ubiquitously Transcribed Tetratricopeptide Repeat on chromosome X (UTX) was identified in 2007 as a specific histone demethylase targeting H3K27me2/3.
• UTX plays essential roles in normal development, including reprogramming, embryonic development, and tissue differentiation.
• UTX is associated with the MLL2 H3K4 methyltransferase complex and influences HOX and RB transcriptional networks.

Purpose of the Study:

• To review the key discoveries concerning UTX's function.
• To highlight UTX's role in development and disease.
• To cover the identification of UTX mutations and inhibitors.

Main Methods:

• Literature review of UTX research from its initial discovery.
• Compilation of studies on UTX's enzymatic and non-enzymatic functions.
• Summary of findings linking UTX to Kabuki syndrome and cancer.

Main Results:

• UTX acts as an H3K27me2/3 demethylase and independently promotes chromatin remodeling with SWI/SNF.
• Constitutional UTX inactivation causes Kabuki syndrome.
• Somatic UTX loss is observed in various human cancers.

Conclusions:

• UTX is a critical epigenetic regulator with dual functions in demethylation and chromatin remodeling.
• UTX mutations and loss are implicated in developmental disorders and cancer.
• Understanding UTX's roles is vital for therapeutic strategies targeting related diseases.